
Research peptides
BPC-157
BPC-157 is a synthetic 15-amino-acid peptide (pentadecapeptide) originally described from a protein in gastric juice.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated, protect from light
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 5 mg, lot BP5-0803: 99.73% purity (RP-HPLC), 5.33 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7609
- 10 mg, lot BP10-0803: 99.71% purity (RP-HPLC), 10.44 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7603
- 15 mg, lot BP15-0803: 99.84% purity (RP-HPLC), 15.75 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7581
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Tendon, ligament and muscle injury models
- Bone healing in animal models
- Gastrointestinal mucosal protection models
- Angiogenesis and nitric oxide signaling
How it is thought to work
The mechanism is not well established. Animal and cell studies have proposed effects on VEGFR2 and nitric oxide signaling (the Akt-eNOS axis), ERK1/2 and FAK-paxillin pathways, and growth hormone receptor expression in fibroblasts. Most of the preclinical literature comes from one research group in Zagreb.
Where the research stands
Mainly preclinical research. Published human data are limited to three small pilot reports with no large controlled trials, and WADA lists BPC-157 as a prohibited non-approved substance (S0).
Sources
- Vasireddi N, et al. (2025). Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal.
- McGuire FP, et al. (2025). Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Current Reviews in Musculoskeletal Medicine.
- Lee E, Burgess K. (2025). Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Alternative Therapies in Health and Medicine.
- PharmaCotherapia d.o.o. (sponsor) (2015). Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157. ClinicalTrials.gov.
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
